<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-id journal-id-type="iso-abbrev">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4472525</article-id><article-id pub-id-type="publisher-id">cc14470</article-id><article-id pub-id-type="doi">10.1186/cc14470</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Randomized, double-blind, placebo-controlled study of the efficacy of four probiotics to modify the risk for postoperative complications in colorectal surgery</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Kotzampassi</surname><given-names>K</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Stavrou</surname><given-names>G</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Damoraki</surname><given-names>G</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Georgitsi</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Basdanis</surname><given-names>G</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Tsaousi</surname><given-names>G</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Giamarellos-Bourboulis</surname><given-names>EJ</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib></contrib-group><aff id="I1"><label>1</label>Aristotle University of Thessaloniki, Greece</aff><aff id="I2"><label>2</label>University of Athens Medical School, Athens, Greece</aff><pub-date pub-type="ppub"><year>2015</year></pub-date><pub-date pub-type="epub"><day>16</day><month>3</month><year>2015</year></pub-date><volume>19</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">35th International Symposium on Intensive Care and Emergency Medicine</named-content><named-content content-type="supplement-sponsor">Pubication charges for this supplement were funded by ISICEM.</named-content></supplement><fpage>P390</fpage><lpage>P390</lpage><permissions><copyright-statement>Copyright &#x000a9; 2015 Kotzampassi et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Kotzampassi et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://ccforum.com/content/19/S1/P390"/><conference><conf-date>17-20 March 2015</conf-date><conf-name>35th International Symposium on Intensive Care and Emergency Medicine</conf-name><conf-loc>Brussels, Belgium</conf-loc></conference></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Heterogeneous published Results led us to conduct a clinical trial to assess the efficacy of a new formulation of four probiotics (P) as prophylaxis for complications after colorectal surgery.</p></sec><sec sec-type="methods"><title>Methods</title><p>A double-blind, placebo-controlled randomized study was conducted enrolling patients undergoing colorectal cancer surgery. Placebo or a formulation of <italic>L. acidophilus</italic>, <italic>L. plantarum</italic>, <italic>B. lactis </italic>and <italic>S. boulardii </italic>was administered starting 1 day before operation and continuing for 15 days post operation. Patients were followed-up for 30 days with the development of postoperative complications as the primary outcome. PAXGene tubes and serum were collected on postoperative day 4 for measurement of gene expression and serum cytokines (<ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">http://ClinicalTrials.gov</ext-link> NCT02313519).</p></sec><sec sec-type="results"><title>Results</title><p>Administration of P significantly decreased the rate of all postoperative major complications (28.6% vs. 48.8% of placebo, <italic>P </italic>= 0.010, odds ratio: 0.42). Major benefit was found in the reduction of the postoperative pneumonia rate (2.4% vs. 11.3%, <italic>P </italic>= 0.029), of wound infections (7.1% vs. 20.0%, <italic>P </italic>= 0.020), of anastomotic leakage (1.2% vs. 8.8%, <italic>P </italic>= 0.031) and of the need for mechanical ventilation (20.2% vs. 35.0%, <italic>P </italic>= 0.037). The time until hospital discharge was shortened as well. Gene expression of SOCS3 was positively related with circulating IL-6 in the P group but not in the placebo group (Figure <xref ref-type="fig" rid="F1">1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><graphic xlink:href="cc14470-1"/></fig></sec><sec sec-type="conclusions"><title>Conclusion</title><p>The studied P formulation significantly decreased the risk of postoperative complications, namely mechanical ventilation, infections and anastomotic leakage. Modulation of the gene expression of SOCS3 is one suggested mechanism.</p></sec></body></article>